SEO URLwww.firestrike.ai/deals/swiss-parenterals-p-eris-lifesciences-acquisition-2026
acquisitionAnnounced · Jan 17, 2026PharmaceuticalsSource · OthersArticle · Factual
Eris Lifesciences acquires Swiss Parenterals P
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Swiss Parenterals P
NSE:SWISS · Jivraj Park, Gujarat
Acquirer
Eris Lifesciences
Full Acquisition
Status
Completed
Eris Lifesciences agreed to acquire Swiss Parenterals P. Reported deal value: Undisclosed. Status: Completed. Sector: Pharmaceuticals. Target headquarters context: Jivraj Park, Gujarat, India.
This page summarizes publicly available information about the transaction as of 2026-01-17. Figures and status may change as filings and press coverage update.
New Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited , making it a wholly owned subsidiary, following the allotment of 23,06,372 equity shares on a preferential basis, the company informed
Deal timeline
Announced
Jan 17, 2026 · medicaldialogues.in
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals. Figures and status may change as sources update.
Sources: medicaldialogues.in · Primary article · FireStrike proprietary index